Download PDF
Thromb Haemost 1995; 74(01): 018-024
DOI: 10.1055/s-0038-1642647
Special Colloquium
Schattauer GmbH Stuttgart

Platelet-Vessel Wall Interaction: from the Bedside to Molecules

Jacques P Caen
Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France
,
Jean-Philippe Rosa
Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
26 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Glanzmann E. Hereditare hämorragische Thrombasthenie. Ein Beitrag zur Pathologie der Blutplattchen Jahr Kinderh 1918; 88: 113-141
    PubMedGoogle Scholar
  • 2 v.Willebrand EA. Hereditar pseudohemofili. Finska Lakaresallskapets Handlingar 1926; 68: 87-112
    PubMedGoogle Scholar
  • 3 Bernard J, and Soulier JP. Sur une nouvelle variete de dystrophie thrombocytaire hemorragipare congenitale. Sem Hop Paris 1948; 24: 3217-3223
    PubMedGoogle Scholar
  • 4 Nilsson IM, Blomback M. Jorpes and Johansson S.A. v Willebrand’s disease and its correction with human plasma fraction. IO Acta Med Scand 1957; 159: 179-179
    PubMedGoogle Scholar
  • 5 Comu P, Larrieu MJ, Caen J, Bernard J. Transfusion studies in von Willebrand’s disease: Effect on bleeding time and Factor VIII. Brit J Haemat 1963; 9: 189-202
    CrossrefPubMedGoogle Scholar
  • 6 Howard MA, Firkin BG. Ristocetin: a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrhag 1972; 26: 362-362
    PubMedGoogle Scholar
  • 7 Caen J, Levy-Toledano S. Interaction between platelets an von Willebrand factor provides a new scheme for primary hemostasis. Nature 1972; 244: 159-160
    PubMedGoogle Scholar
  • 8 Gaarder A, Jonsen JR, Laland S, Hellem A, Owren P. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192: 531-533
    CrossrefPubMedGoogle Scholar
  • 9 Caen J, Cousin C. Le trouble d’adhesivite “in vivo” des plaquettes dans la maladie de Willebrand et les thrombasthenies de Glanzmann. Essai d’interpretation. Nouv Rev Fr Hemat 1962; 2: 685-694
    PubMedGoogle Scholar
  • 10 Caen JP. Glanzmann thrombasthenia. In: Clinics in Hematology-Platelet disorders O’Brien JR. Ed. Publish. W.B. Saunders C°; Ltd. London.: 1972. 1. 383-392
    Google Scholar
  • 11 Nurden AT, Caen JP. An abnormal glycoprotein pattern in 3 cases of Glanzmann thrombasthenia. Brit J Haemat 1974; 28: 253-260
    CrossrefPubMedGoogle Scholar
  • 12 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720-722
    CrossrefPubMedGoogle Scholar
  • 13 Caen JP, Michel H, Bodevin E, Levy-Toledano S. Adhesion and aggregation of human platelet to rabbit subendothelium. A new approach for investigation: specific antibodies. Experientia 1977; 33: 91-93
    CrossrefPubMedGoogle Scholar
  • 14 Fauvel F, Grant MC, Legrand Y, Souchon H, Tobelem G, Jackson DS, Caen JP. Interaction of blood platelets with microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc Natl Acad Sci. USA 1983; 80: 551-554
    CrossrefPubMedGoogle Scholar
  • 15 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein Ilb-IIIa complex. Blood 1988; 71: 831-843
    PubMedGoogle Scholar
  • 16 Bray PF. Inherited diseases of platelet glycoproteins: Considerations for rapid molecular characterisation. Thromb Haemost 1994; 72: 492-502
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-3164
    CrossrefPubMedGoogle Scholar
  • 18 Loftus JC, O’Toole TE, Plow EF, Glass A, Frelinger AL, Ginsberg MH. Apj integrin. Science 1990; 249: 915-918
    CrossrefPubMedGoogle Scholar
  • 19 Djaffar L, Rosa JP. A second case of variant of Glanzmann’s thrombasthenia due substitution of platelet GPIIIa (integrin B3) Arg214 by Tip. Hum Mol Genetics 1993; 2: 2179-2180
    CrossrefPubMedGoogle Scholar
  • 20 Djaffar I, Caen JP, Rosa JP. A large alteration in the human platelet glycoprotein Ilia (integrin 63) gene associated with Glanzmann’s thrombasthenia. Hum Mol Genetics 1993; 2: 2183-2185
    CrossrefPubMedGoogle Scholar
  • 21 Chen Y, Djaffar I, Pidard D, Steiner B, Cieutat AM, Caen JP, Rosa JP. Ser-752-> Pro mutation in the cytoplasmic domain of integrin b3 subunit and defective activation of platelet integrin xr[bp3 (glycoprotein Ilb-IIIa) in a variant of Glanzmann. thrombasthenia Proc Natl Acad Sci USA 1992; 89: 10169-10173
    PubMedGoogle Scholar
  • 22 Chen Y, O’Toole TE, Ylanne J, Rosa JP, Ginsberg MH. A point mutation in the integrin 63 cytoplasmic domain (Ser-752->P) impairs bidirectional signaling through cxIIbp3 (platelet glycoprotein Ilb-IIIa). Blood 1994; 84: 1857-1865
    PubMedGoogle Scholar
  • 23 Lanza F, Stierle A, Fournier D, Morales M, Andre G, Nurden AT, Cazenave JP. A new variant of Glanzmann’s thrombasthenia. Platelets with functionally defective glycoprotein Ilb-IIIa complexes and a glycoprotein Ilia 214Arg-> 214 Trp mutation. J din Invest 1992; 89: 1995-2004
    PubMedGoogle Scholar
  • 24 Bajt ML, Ginsberg MH, Frelinger AL, Bemdt MC, Loftus JC. A spontaneous mutation of integrin (platelet glycoprotein Ilb-IIIa) helps define a ligand binding site. J Biol Chem 1992; 267: 3789-3794
    PubMedGoogle Scholar
  • 25 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagulation Fibrinolysis. 1994; 5: 97-119
    PubMedGoogle Scholar
  • 26 de Marco L, Mazzucato M, Fabris F, de Roia D, Coser P, Girolami A, Vicente V, Ruggeri ZM. Variant Bernard Soulier syndrome type Bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib/IX complex. J din Invest 1990; 86: 25-31
    PubMedGoogle Scholar
  • 27 Ware J, Russel S, Marchese P, Murata M, Mazzucato M, de Marco L, Ruggeri ZM. Point mutation in aleucine-rich repeat of platelet glycoprotein Iba resulting in the Bernard Soulier syndrome. J Clin Invest 1993; 92: 1213-1220
    CrossrefPubMedGoogle Scholar
  • 28 Ware J, Russel S, Vincente V, Scharf RE, Tomer A, McMillan R, Ruggeri ZM. Non-sense mutation in the glycoprotein Iba coding sequence associated with Bernard Soulier syndrome. Proc Natl Acad Sci USA 1990; 87: 2026-2030
    CrossrefPubMedGoogle Scholar
  • 29 Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Iba leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard Soulier syndrome. Blood 1992; 79: 439-446
    PubMedGoogle Scholar
  • 30 Simsek S, Admiraal LG, Modderman PW, van der Schoot EC, von dem Borne AE G Kr. Identification of a homozygous single base pair deletion in the gene coding for the human glycoprotein Iba causing Bernard Soulier syndrome. Thromb Haemostasis 1994; 72: 444-449
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Arai M, Yamamoto N, Akamatsu N, Susuki H, Yamaguchi A, Nishida Y, Fukutake K, Tanoue K. Substantial expression of glycoprotein IX and V on the platelet surface from a patient with Bemard-Soulier syndrome. Br J Haemat 1994; 87: 185-188
    CrossrefPubMedGoogle Scholar
  • 32 de la Salle C, Baas MJ, Lanza F, Schwartz A, Hanau D, Chevalier J, Gachet C, Briquel ME, Cazenave JP. A three base deletion removing a leucine residue in a leucine-rich repeat of platelet glycoprotein Iba associated with a variant of Bemard-Soulier syndrome (Nancy I). Br J Hemat. 1995 89. (in press)
    PubMedGoogle Scholar
  • 33 Wright SD, Michaelides K, Johnson DJD, West NC, Tuddenham EG D. Double heterozygosity for mutations in the platelet glycoprotein DC gene in three siblings with Bemard-Soulier syndrome. Blood 1993; 81: 2339-2347
    PubMedGoogle Scholar
  • 34 Clemetson JM, Kyrle PA, Brenner B, Clemetson K. Variant Bemard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. Blood 1994; 84: 1124-1131
    PubMedGoogle Scholar
  • 35 Miller JL, Cunningham D, Lyle VA, Finch CS. Mutation in the gene encoding the a chain of platelet glycoprotein lb in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-4765
    CrossrefPubMedGoogle Scholar
  • 36 Russel SD, Roth GJ. Pseudo von Willebrand disease: a mutation in the platelet glycoprotein Iba gene associated with a hyper active surface receptor. Blood 1993; 81: 1787-1791
    PubMedGoogle Scholar
  • 37 Ruggeri ZM. Structure and function of von Willebrand factor: relationship to von Willebrand’s disease. Mayo Clin. Proc 1991; 66 (08) 847-861
    CrossrefPubMedGoogle Scholar
  • 38 Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 177-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-525
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Miller JL, Cisse Thiam M, Drouet L. Reduction in thrombosis formation by PG-1 F(ab')2 an antiguinea pig platelet glycoprotein lb monoclonal antibody. Arterioscl Thromb 1991; 11: 1231-1236
    CrossrefPubMedGoogle Scholar
  • 41 Azzam K, Garfinkel LI, Bal dit Sollier C, Cisse Thiam M, Drouet L. Antithrombotic effect of recombinant von Willebrand factor, VCL, on nitrogen laser induced thrombus formation in guinea pig mesenteric arteries. Thromb Haemost 1995; 73: 318-323
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Nichols TC, Samama ChM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M, Brinkhous KM, Pignaud G, Sigman JL, Griggs TR, Drouet L. Altered phenotypes of normal and type III von Willebrand disease pigs by bone marrow transplantation: effects on thrombosis and hemostasis. Proc Natl Acad Sci 1995 (in Press).
    PubMedGoogle Scholar